Abstract

MA10.08 Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up
Shirish M Gadgeel ... Delvys Rodríguez-Abreu
Journal of Thoracic Oncology | VOL. -
Shirish M Gadgeel, et. al.Shirish M Gadgeel ... Delvys Rodríguez-Abreu
01 Apr 2024
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC
...
JTO Clinical and Research Reports | VOL. 4
, et. al. ...
08 Nov 2022
Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407
Ying Cheng ... Luis Paz-Ares
JTO Clinical and Research Reports | VOL. 2
Ying Cheng, et. al.Ying Cheng ... Luis Paz-Ares
25 Sep 2021
140P Preliminary results from PROPEL: A phase I/II study of bempegaldesleukin (BEMPEG: NKTR-214) plus pembrolizumab (PEMBRO) with or without chemotherapy in patients with metastatic NSCLC
...
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 32
, et. al. ...
01 Dec 2021
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
PP01.95 STK11, KEAP1, and KRAS mutation epidemiology and real-world outcomes in US patients with newly diagnosed metastatic non-small cell lung cancer
Firas Dabbous ... Ferdinandos Skoulidis
Journal of Thoracic Oncology | VOL. 19
Firas Dabbous, et. al.Firas Dabbous ... Ferdinandos Skoulidis
01 Jul 2024
PP01.11 Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
Ashwini Arunachalam ... Jerome Goldschmidt
Journal of Thoracic Oncology | VOL. 19
Ashwini Arunachalam, et. al.Ashwini Arunachalam ... Jerome Goldschmidt
01 Jul 2024
PP01.133 Clinical and Economic Outcomes Associated with Genomic Testing Strategies in Real-World Data in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Benjamin Levy ... Teddy Saliba
Journal of Thoracic Oncology | VOL. 19
Benjamin Levy, et. al.Benjamin Levy ... Teddy Saliba
01 Jul 2024
View more papers